{
  "meta": {
    "title": "Lyophilized_Vaccines_Strains_New_Programs_Milestones",
    "url": "https://brainandscalpel.vercel.app/lyophilized-vaccines-strains-new-programs-milestones-907d6b4c.html",
    "scrapedAt": "2025-11-29T18:35:45.910Z"
  },
  "questions": [
    {
      "id": 6331,
      "choices": [
        {
          "id": 25293,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Use the same vial if not exceeded 4 hours from opening of vial</span></span></p>"
        },
        {
          "id": 25294,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If exceeded 4 hrs check for VVM, if VVM is there use the same vial</span></span></p>"
        },
        {
          "id": 25295,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Discard the old opened vial and use new vial&nbsp;</span></span></p>"
        },
        {
          "id": 25296,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Consult the medical officer</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mrs. X, an Auxiliary Nurse Midwife (ANM), is conducting an immunization session at her sub-centre. She has vaccinated three children with the MR (Measles-Rubella) vaccine from a 5-dose vial. After completing this session, she moves to the next village, where she needs to vaccinate one more child with the MR vaccine. Considering best practices in vaccine administration and safety, what should Mrs. X do with the opened MR vaccine vial to vaccinate the child in the new area?</span></span></p>",
      "unique_key": "Q7197891",
      "question_audio": null,
      "question_video": null,
      "map_id": 34102,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Discard the old opened vial and use new vial</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Measles Vaccine</strong> do <strong>not</strong> follow an <strong>open vial policy.</strong>&nbsp; <strong>After reconstitution</strong>, this should be <strong>used</strong> <strong>within 4 hours</strong>. An <strong>opened</strong> vial is generally <strong>discarded</strong> after a <strong>specific period of time</strong> to ensure <strong>its efficacy</strong> and to<strong> maintain its safety</strong>. If the <strong>same vial</strong> is <strong>used</strong>, it may <strong>lead</strong> to <strong>Toxic Shock Syndrome.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Use the same vial if not exceeded 4 hours from the opening of the vial: </strong>&nbsp;As there is change of location, so <strong>new vial</strong> for <strong>vaccinating</strong> the child in the <strong>new area</strong>. This practice <strong>ensures</strong> the <strong>potency</strong> and <strong>safety</strong> of the <strong>vaccine</strong>, <strong>adhering</strong> to <strong>strict vaccine handling</strong> and <strong>administration guidelines.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. If exceeded 4 hours, check for VVM (Vaccine Vial Monitor): </strong>&nbsp;if it shows <strong>viability,</strong> use the <strong>same vial</strong>. <strong>Incorrect.&nbsp;</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Consult the medical officer: &nbsp;</strong>While <strong>consulting</strong> a <strong>medical officer</strong> is a <strong>good practice</strong> in <strong>uncertain</strong> situations, in this case, the <strong>standard protocol</strong> is to <strong>use</strong> a <strong>new vial</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Open Vial Policy 2015</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Not</strong> applicable for <strong>Vaccines</strong>: <strong>Measles, BCG, JE</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Applicable</strong> for Vaccines: <strong>OPV, DPT, Hepatitis B, TT, Liquid Pentavalent -</strong>&nbsp;Opened vaccine vials can be <strong>used</strong> in <strong>subsequent session</strong> <strong>&lsquo;</strong>up to <strong>4 weeks&rsquo;</strong>.&nbsp;</span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The<strong> expiry date</strong> should <strong>not</strong> pass, <strong>VVM</strong> within <strong>usability limits</strong>, <strong>Cold chain</strong> maintenance.&nbsp;<strong>Vaccine vial septum</strong> not submerged in <strong>water</strong> or <strong>contaminated</strong>, <strong>Aseptic</strong> technique used to <strong>withdraw doses</strong>.&nbsp;<strong>Record date</strong> and <strong>time</strong> of <strong>each vial opening.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">At<strong> end of session</strong> return <strong>all open vials</strong> to <strong>Cold chain</strong> -&nbsp;</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Reusable open vials</strong>: <strong>DPT, DT, Hepatitis B, Pentavalent</strong></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Non-reusable</strong> <strong>open vials</strong>: <strong>Measles, BCG, JE</strong> (<strong>Destroy after 48 hours</strong> or <strong>Next session</strong> whichever <strong>earlier</strong>)</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If any <strong>AEFI</strong> reported: <strong>Store all vials</strong> in <strong>Cold chain</strong> till <strong>completion</strong> of <strong>investigation</strong></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>RECENT UPDATE</strong> &ndash; <strong>Rotavirus vaccine</strong> is under <strong>Open Vial Policy</strong>.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vaccines like <strong>OPV, DPT, Hepatitis B, TT, Liquid Pentavalent, rota virus</strong> follow the <strong>Open vial policy</strong>, these can be <strong>used</strong> in <strong>subsequent sessions</strong> &lsquo;up to <strong>4 weeks&rsquo;</strong>.&nbsp;<strong>Open Vial Policy</strong> does <strong>not </strong>apply <strong>to&nbsp;Measles, BCG and Japanese Encephalitis (JE) vaccines.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 26<sup>th</sup> ed pg 117</strong></span></span></p>",
      "correct_choice_id": 25295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6373,
      "choices": [
        {
          "id": 25461,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">​​​​That leads to death</span></span></p>"
        },
        {
          "id": 25462,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Seizures (Non hospitalized)</span></span></p>"
        },
        {
          "id": 25463,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Leading to disability</span></span></p>"
        },
        {
          "id": 25464,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cluster of cases</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In the process of reviewing a poster you created for a Community health talk on vaccine safety, a Senior resident quizzes you about the content, particularly focusing on your list of serious vaccine reactions. He asks you to identify which of the reactions listed on your poster is NOT typically considered a serious adverse event following vaccination. It&#39;s crucial to accurately distinguish between serious and non-serious adverse events to provide correct information to the public. Which of the following reactions, as mentioned on your poster, would not be classified as a serious adverse event following vaccination?</span></span></p>",
      "unique_key": "Q3122377",
      "question_audio": null,
      "question_video": null,
      "map_id": 34103,
      "difficulty_level": "intermediate",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Seizures (Non hospitalized)</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>AEFIs</strong> that are <strong>not</strong> minor but <strong>do not</strong> result in <strong>death</strong>, <strong>hospitalization or disability</strong> are <strong>categorized</strong> as <strong>severe.</strong> Examples include <strong>non-hospitalized cases</strong> of <strong>seizures, hypotonic hyporesponsive episodes (HHEs),</strong> persistent <strong>screaming,</strong> <strong>severe local reaction, injection site abscesses, intussusception</strong>, etc.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>An AEFI</strong> will be <strong>considered serious</strong> if it results in <strong>death (option a)</strong>, requires <strong>hospitalization</strong>, results in <strong>persistent or significant disability (option C)</strong>/incapacity or a <strong>cluster (two or more cases)</strong>&nbsp;<strong>(option D)</strong> of AEFIs occur in a geographical area.</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Adverse effects following immunization (AEFI):</span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Minor Vaccine Reactions:</strong></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-161320.jpg\" style=\"height:273px; width:700px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Rare vaccine reactions:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-162235.jpg\" style=\"height:734px; width:700px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref</u></strong><strong>: Immunization handbook for health workers, 2018, MoHFW, GoI, pg 109,&nbsp;Park 27/e p245</strong></span></span></p>",
      "correct_choice_id": 25462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6377,
      "choices": [
        {
          "id": 25477,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">​​​OPV</span></span></p>"
        },
        {
          "id": 25478,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Influenza</span></span></p>"
        },
        {
          "id": 25479,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Measles</span></span></p>"
        },
        {
          "id": 25480,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tetanus toxoid</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a neurology rotation, medical students delve into the various causes of Guillain-Barre syndrome (GBS), a rare neurological disorder. One particular area of interest is the potential association of GBS with vaccines. While the occurrence is rare, there has been evidence linking certain vaccines to the development of GBS. The students are asked to identify which of the following vaccines has been associated, albeit infrequently, with the development of Guillain-Barre syndrome.</span></span></p>",
      "unique_key": "Q7109577",
      "question_audio": null,
      "question_video": null,
      "map_id": 34101,
      "difficulty_level": "beginner",
      "subjects_id": [
        7
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Influenza</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B:</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Guillain-Barre syndrome</strong> (GBS) is a <strong>rare</strong> vaccine reaction of <strong>Inactivated Influenza vaccine.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Explanation:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. OPV:</strong>&nbsp;<strong>Rare</strong> vaccine <strong>reaction</strong> -<strong>Vaccine-associated paralytic</strong> <strong>Poliomyelitis</strong> (VAPP).</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Measles/ MMR:</strong> <strong>Rare </strong>vaccine reaction - <strong>Febrile seizures,</strong> <strong>Thrombocytopenia, Anaphylaxis, Encephalopathy.</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. TT:</strong>&nbsp;<strong>Rare</strong> vaccine reaction - <strong>Brachial neuritis, Anaphylaxis</strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Educational Objective:</u></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Rare vaccine reactions:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-182142.jpg\" style=\"height:311px; width:700px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>AEFI and Vaccines -&nbsp;</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:16px\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-180930_gt0vF4z.jpg\" style=\"height:527px; width:700px\" /></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u>Ref:</u></strong><strong> Park 27<sup>th</sup> ed pg 245</strong></span></span></p>",
      "correct_choice_id": 25478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}